[Skip to Navigation]
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue
JAMA Network Home
JAMA Cardiology
Sign In

New Online

Current Issue Past Issues

Year

Day

2023 2021
November October
November 29, 2023
Brief Report

Coronary Artery Spasm During Pulsed Field vs Radiofrequency Catheter Ablation of the Mitral Isthmus

Chi Zhang, MD; Petr Neuzil, MD, PhD; Jan Petru, MD; et al.
Abstract Full Text
JAMA Cardiol. Published online November 29, 2023. doi:10.1001/jamacardio.2023.4405

This cohort study compares the incidence and severity of left circumflex arterial vasospasm between pulsed field ablation and radiofrequency ablation during adjacent ablation along the mitral isthmus.

Invited Commentary

Pulsed Field Ablation—Will Coronary Spasm Lead to Iconoclasm?

Bradley P. Knight, MD; Anna Pfenniger, MD, PhD
Abstract Full Text
JAMA Cardiol. Published online November 29, 2023. doi:10.1001/jamacardio.2023.4441
Comment & Response

Can Noncalcified Plaques Contribute to Future Coronary Events?

Muhammed I. Erbay, BS; Shriraj Susarla, BS; Matthew J. Budoff, MD
Abstract Full Text
JAMA Cardiol. Published online November 29, 2023. doi:10.1001/jamacardio.2023.4390

Can Noncalcified Plaques Contribute to Future Coronary Events?—Reply

Alastair J. Moss, PhD; Michelle C. Williams, PhD; David E. Newby, DSc
Abstract Full Text
JAMA Cardiol. Published online November 29, 2023. doi:10.1001/jamacardio.2023.4393
November 22, 2023
Original Investigation

Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical Trial

Antonio Landi, MD; Mirvat Alasnag, MD; Dik Heg, PhD; et al.
Abstract Full Text
JAMA Cardiol. Published online November 22, 2023. doi:10.1001/jamacardio.2023.4316

This comparative effectiveness study, a prespecified analysis from the MASTER DAPT trial, reports sex differences and the association of sex with outcomes among patients with high bleeding risk treated with an abbreviated vs standard dual antiplatelet therapy regimen.

High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism

Behnood Bikdeli, MD, MS; Alfonso Muriel, PhD; Carmen Rodríguez, MD; et al.
Abstract Full Text
JAMA Cardiol. Published online November 22, 2023. doi:10.1001/jamacardio.2023.4356

This cohort study assesses outcomes in patients with pulmonary embolism using high-sensitivity vs conventional troponin I.

From the Heart

We Matched

Katia Bravo-Jaimes, MD
Abstract Full Text
JAMA Cardiol. Published online November 22, 2023. doi:10.1001/jamacardio.2023.4254

In this essay, the author discusses the importance of a Match system that supports and keeps families together while in training.

Editor's Note

High-Sensitivity Troponin in Pulmonary Embolism Risk Stratification—Proceed With Caution

Vinay Guduguntla, MD; Robert O. Bonow, MD, MS
Abstract Full Text
JAMA Cardiol. Published online November 22, 2023. doi:10.1001/jamacardio.2023.4363
November 15, 2023
Original Investigation

Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial

Sanjiv J. Shah, MD; Nowell Fine, MD, SM; Pablo Garcia-Pavia, MD, PhD; et al.
Abstract Full Text
open access has audio
JAMA Cardiol. Published online November 15, 2023. doi:10.1001/jamacardio.2023.4147

This post hoc analysis of the randomized Tafamidis in Transthyretin Cardiomyopathy Clinical Trial examines the effect of tafamidis vs placebo on 30-month changes in cardiac function in patients with transthyretin amyloid cardiomyopathy.

  • Audio: Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy
JAMA Cardiology Clinical Challenge

Irregular Rhythm in a Middle-Aged Man Presenting With New-Onset Heart Failure

Hussam Ali, MD; Ilaria Passarelli, MD; Riccardo Cappato, MD
Abstract Full Text
has active quiz
JAMA Cardiol. Published online November 15, 2023. doi:10.1001/jamacardio.2023.4249

A man in his 50s with recurrent palpitations, fatigue, and progressive exertion dyspnea had irregular narrow-QRS tachycardia in an incessant, repetitive fashion with heart rates up to 180 beats per minute and occasional short runs of wide-QRS tachycardia on Holter monitoring and 12-lead electrocardiogram. What would you do next?

Cardiovascular Images

Swollen Right Upper Limb in a Man in His 60s Undergoing Hemodialysis

Shengmei Liu, MD; Sixian Hu, MD; Liqing Peng, PhD
Abstract Full Text
has active quiz
JAMA Cardiol. Published online November 15, 2023. doi:10.1001/jamacardio.2023.4245

This case report discusses a diagnosis of in-stent thrombus using dual-layer spectral computed tomography with Z-effective images.

November 13, 2023
Original Investigation

Social Determinants of Health

Neighborhood Environmental Burden and Cardiovascular Health in the US

Michael Liu, MPhil; Vishal R. Patel, BS; Renee N. Salas, MD, MPH, MS; et al.
Abstract Full Text
JAMA Cardiol. Published online November 13, 2023. doi:10.1001/jamacardio.2023.4680

This cross-sectional study evaluates associations between environmental burden and cardiovascular risk factors and diseases at the neighborhood level and by levels of social vulnerability.

Brief Report

Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial

Selim R. Krim, MD; Senthil Anand, MD; Stephen J. Greene, MD; et al.
Abstract Full Text
JAMA Cardiol. Published online November 13, 2023. doi:10.1001/jamacardio.2023.4776

This post hoc analysis of the Torsemide Comparison With Furosemide for Management of Heart Failure (TRANSFORM-HF) randomized clinical trial investigates if torsemide improves mortality and hospitalization outcomes at 12 months compared with furosemide in either de novo heart failure or worsening chronic heart failure.

Invited Commentary

Social Determinants of Health

Prioritizing the Exposome to Reduce Cardiovascular Disease Burden

Erica S. Spatz, MD, MHS; Kai Chen, PhD; Harlan M. Krumholz, MD, SM
Abstract Full Text
JAMA Cardiol. Published online November 13, 2023. doi:10.1001/jamacardio.2023.4722
November 12, 2023
Original Investigation

Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial

Finnian R. Mc Causland, MBBCh, MMSc; Brian L. Claggett, PhD; Muthiah Vaduganathan, MD, MPH; et al.
Abstract Full Text
JAMA Cardiol. Published online November 12, 2023. doi:10.1001/jamacardio.2023.4664

This prespecified analysis of the Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure (DELIVER) randomized clinical trial investigates the association of initial changes in estimated glomerular filtration rate with cardiovascular and kidney outcomes in patients with heart failure and mildly reduced or preserved ejection fraction.

November 11, 2023
Original Investigation

Natural Language Processing for Adjudication of Heart Failure in a Multicenter Clinical Trial: A Secondary Analysis of a Randomized Clinical Trial

Jonathan W. Cunningham, MD, MPH; Pulkit Singh, BA; Christopher Reeder, PhD; et al.
Abstract Full Text
JAMA Cardiol. Published online November 11, 2023. doi:10.1001/jamacardio.2023.4859

This secondary analysis of a randomized clinical trial validates the findings of a single-center study regarding the use of natural language processing for the adjudication of heart failure hospitalization.

Editorial

Innovation in Event Adjudication—Human vs Machine

Kenneth W. Mahaffey, MD; C. Michael Gibson, MS, MD; Renato D. Lopes, MD, MHS, PhD
Abstract Full Text
JAMA Cardiol. Published online November 11, 2023. doi:10.1001/jamacardio.2023.4900
November 8, 2023
Original Investigation

Long-Term Clinical and Echocardiographic Outcomes Following the Ross Procedure: A Post Hoc Analysis of a Randomized Clinical Trial

Maximiliaan L. Notenboom, BSc; Giovanni Melina, MD, PhD; Kevin M. Veen, MD, PhD; et al.
Abstract Full Text
JAMA Cardiol. Published online November 8, 2023. doi:10.1001/jamacardio.2023.4090

This post hoc analysis of a randomized clinical trial assesses long-term survival after the Ross procedure among adults.

Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant

June-Wha Rhee, MD; Raju Pillai, MD; Tianhui He, MPH; et al.
Abstract Full Text
open access
JAMA Cardiol. Published online November 8, 2023. doi:10.1001/jamacardio.2023.4105

This study examines the association between clonal hematopoiesis of indeterminate potential and cardiovascular disease in patients with multiple myeloma.

Invited Commentary

The Longest Reported Outcomes of the Ross Procedure

Tsuyoshi Kaneko, MD; Maral Ouzounian, MD, PhD
Abstract Full Text
JAMA Cardiol. Published online November 8, 2023. doi:10.1001/jamacardio.2023.4100
Review

Mendelian Randomization as a Tool for Cardiovascular Research: A Review

Michael G. Levin, MD; Stephen Burgess, PhD
Abstract Full Text
has active quiz
JAMA Cardiol. Published online November 8, 2023. doi:10.1001/jamacardio.2023.4115

This narrative review describes the strengths, limitations, and applications of mendelian methodology in research.

Editor's Note

Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership

Pradeep Natarajan, MD, MMSc; Clyde W. Yancy, MD, MSc
Abstract Full Text
JAMA Cardiol. Published online November 8, 2023. doi:10.1001/jamacardio.2023.4126
Correction

Corrected to Open Access Status

Abstract Full Text
free access
JAMA Cardiol. Published online November 8, 2023. doi:10.1001/jamacardio.2023.4300
November 1, 2023
Original Investigation

Educational Attainment and Lifetime Risk of Cardiovascular Disease

Jared W. Magnani, MD, MSc; Hongyan Ning, MS; John T. Wilkins, MD, MSc; et al.
Abstract Full Text
JAMA Cardiol. Published online November 1, 2023. doi:10.1001/jamacardio.2023.3990

This study attempts to calculate lifetime risk estimates of incident cardiovascular disease (CVD) and CVD subtypes and estimate years lived with and without CVD by education.

Clinical Outcomes by Sex After Pulsed Field Ablation of Atrial Fibrillation

Mohit K. Turagam, MD; Petr Neuzil, MD, PhD; Boris Schmidt, MD; et al.
Abstract Full Text
JAMA Cardiol. Published online November 1, 2023. doi:10.1001/jamacardio.2023.3752

This cohort study investigates if patient sex is associated with clinical outcomes of pulsed field ablation for the treatment of individuals with atrial fibrillation.

Research Letter

Prevalence, Awareness, and Treatment of Elevated LDL Cholesterol in US Adults, 1999-2020

Ahmed Sayed, MBBS; Ann Marie Navar, MD, PhD; Leandro Slipczuk, MD, PhD; et al.
Abstract Full Text
JAMA Cardiol. Published online November 1, 2023. doi:10.1001/jamacardio.2023.3931

This cross-sectional study compares the prevalence, awareness, and treatment of elevated low-density lipoprotein (LDL) cholesterol in US adults in 1999-2000 vs 2017-2020.

Invited Commentary

Pulsed Field Closes Gender Gap in Atrial Fibrillation Ablation—Electrifying Insights

Peter M. Kistler, MBBS, PhD; Louise Segan, MBBS, MPH
Abstract Full Text
JAMA Cardiol. Published online November 1, 2023. doi:10.1001/jamacardio.2023.4009

Latest Issue

Fractional Flow Reserve–Negative High-Risk Plaques and Clinical Outcomes After Myocardial Infarction
Original Investigation | November 1, 2023
Long-Term Quality of Life After Out-of-Hospital Cardiac Arrest
Original Investigation | November 1, 2023
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial
Original Investigation | November 1, 2023
View More
×
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Sign in to access free PDF
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Save your search
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Make a comment
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
  • Register for email alerts with links to free full-text articles
  • Access PDFs of free articles
  • Manage your interests
  • Save searches and receive search alerts
Privacy Policy